J&J, Merck and Bristol Myers Squibb CEOs Testify at Senate Hearing on Drug Pricesnews2024-02-08T21:15:51+00:00February 8th, 2024|The New York Times|
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
Johnson & Johnson Reaches Deal for $8.9 Billion Talc Settlementnews2023-04-05T01:25:02+00:00April 5th, 2023|The New York Times|
Fabricantes de vacunas se quedaron con 1400 millones USD en anticiposnews2023-02-04T10:00:24+00:00February 4th, 2023|The New York Times|
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nationsnews2023-02-01T17:44:17+00:00February 1st, 2023|The New York Times|
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?news2023-01-18T21:26:06+00:00January 18th, 2023|The New York Times|
Johnson & Johnson Will Discontinue Talc-Based Baby Powder Globally in 2023news2022-08-12T02:53:50+00:00August 12th, 2022|The New York Times|
McKinsey Guided Companies at the Center of the Opioid Crisisnews2022-06-29T23:24:22+00:00June 29th, 2022|The New York Times|
Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64news2022-04-30T19:09:09+00:00April 30th, 2022|The New York Times|
Lawmakers Dismiss McKinsey’s Apology on Opioid Crisis as ‘Empty’news2022-04-27T22:34:40+00:00April 27th, 2022|The New York Times|
